Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-003846-97Phase 2Terminated
Phase 2 trial of mirtazapine in tension-type headache (TTH), sponsored by Aarhus University. Primary endpoint: Headache days and severity. Started Oct 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-003846-97.